Does DABRAFENIB\TRAMETINIB Cause Malignant neoplasm progression? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Malignant neoplasm progression have been filed in association with DABRAFENIB\TRAMETINIB. This represents 8.0% of all adverse event reports for DABRAFENIB\TRAMETINIB.
9
Reports of Malignant neoplasm progression with DABRAFENIB\TRAMETINIB
8.0%
of all DABRAFENIB\TRAMETINIB reports
2
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From DABRAFENIB\TRAMETINIB?
Of the 9 reports, 2 (22.2%) resulted in death, 2 (22.2%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB\TRAMETINIB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB\TRAMETINIB Cause?
Pyrexia (21)
Rash (11)
Therapeutic response decreased (11)
Disease progression (8)
Drug resistance (8)
Drug ineffective (7)
Nausea (7)
Arthralgia (6)
Vomiting (6)
Diarrhoea (5)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which DABRAFENIB\TRAMETINIB Alternatives Have Lower Malignant neoplasm progression Risk?
DABRAFENIB\TRAMETINIB vs DACARBAZINE
DABRAFENIB\TRAMETINIB vs DACLATASVIR
DABRAFENIB\TRAMETINIB vs DACLIZUMAB
DABRAFENIB\TRAMETINIB vs DACOMITINIB
DABRAFENIB\TRAMETINIB vs DACTINOMYCIN